Coagulation in sepsis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Intensive Care Medicine

• Publication date

  2004-05-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00134-004-2291-8PMID 15148567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coagulation and sepsis.

  2006cited by this paper
• clinical investigations in critical care Time Course of Hemostatic Abnormalities in Sepsis and its Relation to Outcome *

  2006cited by this paper
• Protein C and S deficiency in severe infectious purpura of children: A collaborative study of 40 cases

  2005cited by this paper
• An updated view of hemostasis: mechanisms of hemostatic dysfuntion associated with sepsis

  2005cited by this paper
• Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation 1

  2004cited by this paper
• Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis.

  2004cited by this paper
• Hemostatic changes in dogs with naturally occurring sepsis.

  2003cited by this paper
• [Disseminated intravascular coagulation].

  2003cited by this paper
• Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

  2003cited by this paper
• Coagulation disorders in liver disease.

  2002cited by this paper
• Success or Failure in Phase III Sepsis Trials : Comparisons between the Drotrecogin Alfa ( Activated ) and Antithrombin III Clinical Trials

  2002cited by this paper
• Endothelium and disordered fibrin turnover in the injured lung: Newly recognized pathways

  2002cited by this paper
• Activated protein C for severe sepsis.

  2002cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock

  2001cited by this paper
• Microvascular coagulopathy and disseminated intravascular coagulation

  2001cited by this paper
• D-dimer testing: the role of the clinical laboratory in the diagnosis of pulmonary embolism.

  2001cited by this paper
• Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.

  2001cited by this paper
• Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis*

  2001cited by this paper
• A Cell-based Model of Hemostasis

  2001cited by this paper
• Effects of antithrombin III on tumor necrosis factor-alpha and interleukin-1beta synthesis in vascular smooth muscle cells.

  2001cited by this paper
• Effects of Antithrombin III on Tumor Necrosis Factor-α and Interleukin-1β Synthesis in Vascular Smooth Muscle Cells

  2001cited by this paper
• High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial

  2001cited by this paper
• Role of thrombin signalling in platelets in haemostasis and thrombosis

  2001cited by this paper
• Tissue Factor: An Enzyme Cofactor and a True Receptor

  2001cited by this paper
• Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

  2001cited by this paper
• Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation

  2001cited by this paper
• Regulation of Fibrinolysis in Plasma by TAFI and Protein C Is Dependent on the Concentration of Thrombomodulin

  2001cited by this paper
• Role of Coagulation Inhibitors in Inflammation

  2001cited by this paper
• The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis

  2001cited by this paper
• Activated protein C inhibits lipopolysaccharide‐induced nuclear translocation of nuclear factor κB (NF‐κB) and tumour necrosis factor α (TNF‐α) production in the THP‐1 monocytic cell line

  2000cited by this paper
• Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions.

  2000cited by this paper
• Activated Protein C Reduces the Ischemia/Reperfusion-Induced Spinal Cord Injury in Rats by Inhibiting Neutrophil Activation

  2000cited by this paper
• Therapeutic rationale for antithrombin III in sepsis

  2000cited by this paper
• Endothelial cell expression of monocyte chemotactic protein-1, tissue factor, and thrombomodulin on hydrophilic plasma polymers.

  2000cited by this paper
• Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.

  2000cited by this paper
• The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis.

  2000cited by this paper
• Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?

  2000cited by this paper
• Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-alpha.

  1999cited by this paper
• Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin.

  1999influential reference
• The Biology of P-Selectin Glycoprotein Ligand-1: Its Role as a Selectin Counterreceptor in Leukocyte-Endothelial and Leukocyte-Platelet Interaction

  1999cited by this paper
• Mechanism of Action of Plasminogen Activators

  1999cited by this paper
• Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro.

  1998cited by this paper
• Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.

  1998cited by this paper
• Tissue factor expression by monocytes: regulation and pathophysiological roles.

  1998cited by this paper
• Tissue factor expression by monocytes: regulation and pathophysiological roles.

  1998cited by this paper
• Acute generalized, widespread bleeding. Diagnosis and management.

  1998cited by this paper
• Antithrombin III (AT III) Prevents LPS-Induced Pulmonary Vascular Injury: Novel Biological Activity of AT III

  1997cited by this paper
• The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity.

  1997cited by this paper
• Inhibitory Mechanism of the Protein C Pathway on Tissue Factor-induced Thrombin Generation

  1997cited by this paper
• Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.

  1997cited by this paper
• Regulation of Tissue Factor Initiated Thrombin Generation by the Stoichiometric Inhibitors Tissue Factor Pathway Inhibitor, Antithrombin-III, and Heparin Cofactor-II*

  1997cited by this paper
• Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion.

  1997cited by this paper
• Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.

  1996cited by this paper
• Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis

  1996cited by this paper
• The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.

  1996cited by this paper
• Transmission of a procoagulant signal from tissue factor‐bearing cells to platelets

  1996cited by this paper
• The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.

  1996cited by this paper
• Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells

  1995cited by this paper
• Plasma carboxypeptidases as regulators of the plasminogen system.

  1995cited by this paper
• Coagulation Activation and Tissue Necrosis in Meningococcal Septic Shock: Severely Reduced Protein C Levels Predict a High Mortality

  1995cited by this paper
• Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome.

  1995cited by this paper
• P-selectin and platelet-activating factor mediate initial endotoxin- induced neutropenia

  1994cited by this paper
• Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.

  1994cited by this paper
• Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation

  1994cited by this paper
• Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.

  1993influential reference
• Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.

  1993cited by this paper
• Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism.

  1993cited by this paper
• Platelets contain releasable coagulation factor IX antigen

  1993cited by this paper
• The roles of fibrinogen and fibrin in hemostasis and thrombosis.

  1992cited by this paper
• Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils.

  1992cited by this paper
• Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.

  1992cited by this paper
• Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute‐phase proteins during the treatment of severe sepsis in humans

  1992cited by this paper
• Why do hemophiliacs bleed?

  1992cited by this paper
• Molecular basis of inherited human antithrombin deficiency.

  1992cited by this paper
• The roles of fibrinogen and fibrin in hemostasis and thrombosis.

  1992cited by this paper
• C4b-binding protein exacerbates the host response to Escherichia coli.

  1991cited by this paper
• Protein C, Protein S and c4b-Binding Protein in Severe lnfection and Septic Shock

  1991cited by this paper
• Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.

  1991cited by this paper
• Soluble Thrombomodulin Antigen in Conditioned Medium Is Increased by Damage of Endothelial Cells

  1991cited by this paper
• Fibrinolysis and Coagulation in Patients with Infectious Disease and Sepsis

  1991cited by this paper
• Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome.

  1989cited by this paper
• Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells.

  1989influential reference
• Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.

  1988cited by this paper
• Expression of tissue factor and factor VIIa/tissue factor inhibitor activity in endotoxin or phorbol ester stimulated U937 monocyte-like cells.

  1988cited by this paper
• Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells

  1988cited by this paper
• Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.

  1987influential reference
• Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.

  1986influential reference
• Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor.

  1985cited by this paper
• Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.

  1985cited by this paper
• The roles of protein C and thrombomodulin in the regulation of blood coagulation.

  1984cited by this paper
• Early events in the formation of a venous thrombus following local trauma and stasis.

  1984cited by this paper
• Human Plasma Protein C: ISOLATION, CHARACTERIZATION, AND MECHANISM OF ACTIVATION BY α-THROMBIN

  1979cited by this paper
• Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.

  1979cited by this paper
• Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

  1977cited by this paper
• Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex.

  1973cited by this paper
• The effect of plasmin on the subunit structure of human fibrin.

  1973cited by this paper
• Factor‐Xa Inactivation by Antithrombin III

  1973cited by this paper
• The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor).

  1971cited by this paper
• An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier

  1964cited by this paper

• Hemolysis, hemolytic markers, and mortality in sepsis: a scoping review

  2025cites this paper
• The association between coagulation function and prognosis in patients with sepsis: a meta-analysis of predictive performance introduction

  2025cites this paper
• D-dimer as a Marker of Clinical Outcome in Children with Sepsis: A Tertiary Care Centre Experience

  2025cites this paper
• p38 Protein as a Therapeutic Target for Sepsis-Induced Organ Dysfunction.

  2025cites this paper
• Risk factor analysis for deep vein thrombosis in children with acute hematogenous osteomyelitis

  2025cites this paper
• Association between D-dimer to lymphocyte ratio and in hospital all-cause mortality in elderly patients with sepsis: a cohort of 1123 patients

  2025cites this paper
• Descriptive Epidemiology of Venous Thromboembolism in Pediatric Orthopedic Patients

  2025cites this paper
• Multifunctional Co‐Delivery Systems with Downregulation of the Novel Target PIM1 in Macrophages to Ameliorate TF‐Mediated Coagulopathy in Sepsis

  2025cites this paper
• Prognostic gene landscapes and therapeutic insights in sepsis-induced coagulopathy.

  2024cites this paper
• The value of D-dimer-albumin ratio as a prognostic biomarker in critically ill patients with sepsis: A retrospective single-center study

  2024cites this paper
• Effect of therapeutic plasma exchange on tissue factor and tissue factor pathway inhibitor in septic shock

  2024cites this paper
• The Recruitment and Activation of Plasminogen by Bacteria—The Involvement in Chronic Infection Development

  2023cites this paper
• Acute lung injury caused by sepsis: how does it happen?

  2023cites this paper
• Haematological Perspective of Some Mosaic Laws

  2023cites this paper
• STING activation in platelets aggravates septic thrombosis by enhancing platelet activation and granule secretion.

  2023cites this paper
• Pretreatment with Eupatilin Attenuates Inflammation and Coagulation in Sepsis by Suppressing JAK2/STAT3 Signaling Pathway

  2023cites this paper
• Comparisons of coagulation characteristics between elderly and non-elderly patients with sepsis: A prospective study.

  2023cites this paper
• Role of pyroptosis in hemostasis activation in sepsis

  2023influential citation
• D-dimer may aid in the diagnosis of pediatric musculoskeletal infections: a prospective study

  2022cites this paper
• Dissecting the correlates of N-terminal prohormone brain natriuretic peptide in acute infective endocarditis

  2022cites this paper
• Prevalence of Acute Pulmonary Embolism at Autopsy in Patients With COVID-19

  2022cites this paper
• Thymoquinone modulates the expression of sepsis-related microRNAs in a CLP model

  2022cites this paper
• Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy

  2022cites this paper
• Recommendations from the ICM-VTE: Pediatric.

  2022cites this paper
• Frequency of Atrial Arrhythmia in Hospitalized Patients With COVID-19

  2021cites this paper
• Hypercoagulability in Septic Shock Patients With Thrombocytopenia

  2021cites this paper
• The Expanding Role of Biomarkers in Diagnosing Infection in Total Joint Arthroplasty: A Review of Current Literature.

  2021cites this paper
• A Meta-Analysis of the Correlation between Cardiac Troponin I and the Prognosis of Sepsis

  2021cites this paper
• Clinical Treatment of Perioperative Disseminated Intravascular Coagulation in Patients Who Underwent Gastrointestinal and Hepato-Biliary-Pancreatic Surgery

  2021cites this paper
• Coagulation Dysfunction in Acute Respiratory Distress Syndrome and Its Potential Impact in Inflammatory Subphenotypes

  2021influential citation
• Clinical features and risk factors for severe-critically ill COVID-19 adult patients in Jiangsu, China

  2021cites this paper
• Clinical characteristics and risk factors for severe-critically ill COVID-19 adult patients in Jiangsu, China: a multiple-centered, retrospective study

  2020cites this paper
• Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus

  2020cites this paper
• Bmal1 Regulates Coagulation Factor Biosynthesis in Mouse Liver in Streptococcus oralis Infection

  2020cites this paper
• The multifaceted role of fibrinogen in tissue injury and inflammation.

  2019cites this paper
• Procalcitonin and D-dimer for Predicting 28-Day-Mortality Rate and Sepsis Severity based on SOFA Score; A Cross-sectional Study

  2019cites this paper
• Metformin-attenuated sepsis-induced oxidative damages: a novel role for metformin

  2018cites this paper
• Glucono-Delta-Lactone Inhibits Tissue Factor and Thrombin Activity during Human Blood Coagulation

  2018cites this paper
• The impact of septic stimuli on the systemic inflammatory response and physiologic insult in a preclinical non-human primate model of polytraumatic injury

  2018cites this paper
• 8 Cellular Mechanisms of MOF During Severe Sepsis and Septic Shock

  2018cites this paper
• Antithrombin deficiency is associated with mortality and impaired organ function in septic pediatric patients: a retrospective study

  2018cites this paper
• Disorders of the Gastrointestinal System

  2017cites this paper
• Pathology of wild-type and toxin-independent Bacillus anthracis meningitis in rabbits

  2017cites this paper
• Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis

  2017cites this paper
• Anticoagulant Therapy in Sepsis. The Importance of Timing

  2017cites this paper
• Hämostasestörungen – Diagnostik und Therapie

  2016cites this paper
• Nonactivated Protein C in the Treatment of Neonatal Sepsis: A Retrospective Analysis of Outcome

  2016cites this paper
• Usefulness of the Mortality in Severe Sepsis in the Emergency Department score in an urban tertiary care hospital.

  2016cites this paper
• Polymyxin B Direct Hemoperfusion Using Regional Citrate-Calcium Anticoagulation: A Case Report.

  2016cites this paper
• Potential diagnostic markers for disseminated intravascular coagulation of sepsis.

  2016cites this paper
• The melding of nanomedicine in thrombosis imaging and treatment: a review

  2016cites this paper
• Are Global Coagulation and Platelet Parameters Useful Markers for Predicting Late-Onset Neonatal Sepsis?.

  2016cites this paper
• Vasopressin V1A receptors mediate the stabilization of intestinal mucosal oxygenation during hypercapnia in septic rats.

  2016cites this paper
• Microcirculatory Changes in TermNewborns with Suspected Infection: An Observational Prospective Study

  2015cites this paper
• Estudo do perfil de coagulação em pacientes oncológicos com injúria renal aguda

  2015cites this paper
• Analysis of the influence of antithrombin on microvascular thrombosis: anti-inflammation is crucial for anticoagulation

  2015cites this paper
• A PREGNANT WOMAN WITH AVIAN INFLUENZA A (H7N9) VIRUS PNEUMONIA AND ARDS MANAGED WITH EXTRACORPOREAL MEMBRANE OXYGENATION.

  2015cites this paper
• Pre-existing atrial fibrillation and risk of arterial thromboembolism and death in intensive care unit patients: a population-based cohort study

  2015cites this paper
• Platelet activation in a population of critically ill dogs as measured with whole blood flow cytometry and thromboelastography.

  2015cites this paper
• A randomized clinical trial of unfractioned heparin for treatment of sepsis ( the HETRASE study ) : design and rationale [ NCT 00100308 ]

  2015cites this paper
• Clinical significance of plasma level of AT-栿 determination in sepsis patients

  2015cites this paper
• zur Erlangung des akademischen Grades Doctor medicinae (Dr. med.)

  2015influential citation
• Pre-existing atrial fibrillation and risk of arterial thromboembolism and death following pneumonia: a population-based cohort study

  2014cites this paper
• Peripheral mitochondrial function in multiple organ dysfunction syndrome

  2014influential citation
• Should β-blockers be used in septic shock?

  2014cites this paper
• Chapter 11 – Systemic Inflammatory Response Syndrome

  2014cites this paper
• Deep vein thrombosis in a child with osteoarticular infection: A case report

  2014cites this paper
• Proteomics reveals age-related differences in the host immune response to sepsis.

  2014cites this paper
• Bacterial RTX Toxins Allow Acute ATP Release from Human Erythrocytes Directly through the Toxin Pore*

  2014cites this paper
• Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study

  2014cites this paper
• Risk factors for septic shock in acute obstructive pyelonephritis requiring emergency drainage of the upper urinary tract

  2014cites this paper
• The role of proteomics in understanding biological mechanisms of sepsis

  2014cites this paper
• Protecting travelling pets and their owners from disease – the role of the veterinarian

  2014cites this paper
• Structural and functional aspects of factor viii in the initiation of the anti-factor viii immune response

  2014cites this paper
• Prognostic value of the International Society on Thrombosis and Haemostasis scoring system for overt disseminated intravascular coagulation in emergency department sepsis

  2014cites this paper
• Microcirculatory Changes in Term Newborns with Suspected Infection: An Observational Prospective Study

  2013cites this paper
• Mechanism of Ascorbate Protection Against Sepsis-Induced Capillary Blood Flow Impairment

  2013cites this paper
• thrombosis in a child with osteoarticular infection: A case report

  2013cites this paper
• Microparticles and acute renal dysfunction in septic patients.

  2013cites this paper
• Novel biomarkers for early prediction of sepsis-induced disseminated intravascular coagulation in a mouse cecal ligation and puncture model

  2013cites this paper
• severe protein C deficiency Acute inflammation is exacerbated in mice genetically predisposed to a

  2013cites this paper
• The MISSED score, a new scoring system to predict Mortality In Severe Sepsis in the Emergency Department: a derivation and validation study

  2013cites this paper
• Life-threatening acute disseminated staphylococcal disease in a child.

  2013cites this paper
• Down-regulated expression of AQP5 on lung in rat DIC model induced by LPS and its effect on the development of pulmonary edema.

  2013cites this paper
• Septic shock: The initial moments and beyond

  2013cites this paper
• CONGENITAL BILIARY TRACT MALFORMATION RESEMBLING BILIARY CYSTADENOMA IN A CAPTIVE JUVENILE AFRICAN LION (PANTHERA LEO)

  2012cites this paper
• Profile of thrombin generation in children with acute lymphoblastic leukemia treated by Berlin–Frankfurt–Münster (BFM) protocols

  2012cites this paper
• D-dimer is a significant prognostic factor in patients with suspected infection and sepsis.

  2012cites this paper
• Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-κB activation on endothelial cell.

  2012cites this paper
• Congenital biliary tract malformation resembling biliary cystadenoma in a captive juvenile African lion (Panthera leo).

  2012cites this paper
• Nodakenin Suppresses Lipopolysaccharide-Induced Inflammatory Responses in Macrophage Cells by Inhibiting Tumor Necrosis Factor Receptor-Associated Factor 6 and Nuclear Factor-κB Pathways and Protects Mice from Lethal Endotoxin Shock

  2012cites this paper
• Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting TRAF6 and NF-κ B pathways and protects mice from lethal endotoxin shock

  2012cites this paper
• Early diagnostic markers of sepsis after oesophagectomy (including thromboelastography)

  2012cites this paper
• Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation

  2012cites this paper
• Sepsis: a review for the neurohospitalist.

  2012cites this paper
• D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial.

  2012cites this paper
• Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting TRAF 6 and NF-κ B pathways and protects mice from lethal endotoxin shock

  2012cites this paper
• Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury

  2012cites this paper
• Assessment of the Effect of Induced Hypothermia in Experimental Sepsis Using a Cecal Ligation and Perforation Mouse Model

  2011influential citation
• Pulmonary embolism in critically ill patients receiving antithrombotic prophylaxis: a clinical-pathologic study.

  2011cites this paper